asthma

Syndicate content

Pharmacists as educators can improve asthma outcomes

New research has shown that up to 90 per cent of people on asthma medications are using their inhalers incorrectly leading to poor asthma control, increased hospital visits and increased cost of treatment.

Get the full story...

Role of fish-based fatty acids in resolving, preventing asthma

In an ongoing effort to determine the anti-inflammatory value of diets rich in some types of fish, scientists studying asthma and allergic reactions have found that a molecule produced by the body from omega-3 fatty acids helps resolve and prevent respiratory distress in laboratory mice.

Get the full story...

Allergy expert has advice for flood victims

As if the emotional and financial impact of flood damage isn't bad enough, floodwaters can also bring health problems. H. James Wedner, M.D., professor of medicine and chief of the Division of Allergy and Immunology at Washington University School of Medicine in St. Louis, says after the water recedes, damp homes and businesses are fertile grounds for mold growth, which can cause allergic reactions and asthmatic symptoms in sensitive people.

Get the full story...

Caesarean sections associated with risk of asthma

Babies born by Caesarean section have a 50 % increased risk of developing asthma compared to babies born naturally. Emergency Caesarean sections increase the risk even further. This is shown in a new study based on data from 1.7 million births registered at the Medical Birth Registry at the Norwegian Institute of Public Health.

Get the full story...

sNDA for Symbicort for treatment of asthma in children

AstraZeneca announced that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for approval of a new indication for SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol for the long-term maintenance treatment of asthma in pediatric patients ages 6 to 11 years old.

Get the full story...

New breathing exercises help manage asthma

A presentation that demonstrates breathing exercises designed to help reduce the use of asthma inhalers is today available to the general public for free from the Cooperative Research Centre (CRC) for Asthma and Airways website.

Get the full story...

New patient satisfaction study with budesonide, formoterol combination therapy

A new open-label study evaluated patient satisfaction with budesonide/formoterol combination therapy and fluticasone/salmeterol combination therapy, as measured by the Asthma Treatment Satisfaction Measure (ATSM).1

Get the full story...

Can early cat ownership protect children at-risk for asthma?

A study released by researchers at the Columbia Center for Children's Environmental Health (CCCEH) at Columbia University’s Mailman School of Public Health, shows that cat ownership may have a protective effect against the development of asthma symptoms in young children at age five.

Get the full story...

Study analyzed SYMBICORT in children with persistent asthma

A new 12-week study2examined safety and efficacy measures of the maintenance combination asthma therapy, SYMBICORT® (budesonide/formoterol fumarate dehydrate) Inhalation Aerosol,2 in treating mild to moderate persistent asthma in children ages 6 to 15 years old2 who were previously treated with an inhaled corticosteroid (ICS).2 Of note.

Get the full story...

First-born babies' higher asthma and allergy rates due to pregnancy conditions

First-born children are at higher risk of developing asthma and allergy because of different conditions they experience in the uterus, according to new research from the Isle of Wight in the United Kingdom, which will be presented at the American Thoracic Society’s 2008 International Conference in Toronto on Wednesday, May 21.

Get the full story...

Mother's prenatal stress predisposes their babies to asthma, allergy

Women who are stressed during pregnancy may pass some of that frazzlement to their fetuses in the form of increased sensitivity to allergen exposure and possibly future asthma risk, according to researchers from Harvard Medical School who will present their findings at the American Thoracic Society’s 2008 International Conference in Toronto on Sunday, May 18.

Get the full story...

Personalized therapy for asthma and COPD could soon be here

Researchers at Washington University School of Medicine in St. Louis have defined a new type of immune response that is activated in patients with severe asthma and COPD (chronic obstructive pulmonary disease). Their discovery could dramatically improve diagnosis and treatment of patients with chronic inflammatory lung disease.

Get the full story...